Is ORCX or JNJ a better dividend investment in 2026?

ORCX currently yields 7.49% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ORCX offers higher current income.

What is the dividend yield difference between ORCX and JNJ?

ORCX has a forward dividend yield of 7.49% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 4.13 percentage points.

Home › Compare › ORCX vs JNJ

ORCX vs JNJ: Dividend Comparison 2026

ORCX yields 7.49% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ORCX wins by $12.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ORCX

● Live price

7.49%

Share price

$26.69

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32.8K

Annual income

$1,205.04

Full ORCX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ORCX vs JNJ

📍 ORCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ORCX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ORCX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ORCX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORCX

Annual income on $10K today (after 15% tax)

$636.94/yr

After 10yr DRIP, annual income (after tax)

$1,024.28/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ORCX beats the other by $320.67/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORCX + JNJ for your $10,000?

ORCX: 50%JNJ: 50%

100% JNJ50/50100% ORCX

Portfolio after 10yr

$26.4K

Annual income

$1,016.41/yr

Blended yield

3.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ORCX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORCX buys

JNJ buys

No recent congressional trades found for ORCX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricORCXJNJ

Forward yield	7.49% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$32.8K ✓	$20.0K
Annual income after 10y	$1,205.04 ✓	$827.78
Total dividends collected	$9.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ORCX vs JNJ ($10,000, DRIP)

Year	ORCX Portfolio	ORCX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,449	$749.34	$10,676	$355.77	+$773.00 → ORCX
2	$13,053	$801.82	$11,407	$389.39	+$1.6K → ORCX
3	$14,821	$854.30	$12,198	$426.53	+$2.6K → ORCX
4	$16,765	$906.56	$13,056	$467.62	+$3.7K → ORCX
5	$18,897	$958.38	$13,987	$513.12	+$4.9K → ORCX
6	$21,229	$1,009.59	$14,998	$563.56	+$6.2K → ORCX
7	$23,775	$1,060.00	$16,098	$619.52	+$7.7K → ORCX
8	$26,549	$1,109.46	$17,295	$681.69	+$9.3K → ORCX
9	$29,565	$1,157.85	$18,599	$750.82	+$11.0K → ORCX
10	$32,839	$1,205.04	$20,022	$827.78	+$12.8K → ORCX

ORCX vs JNJ: Complete Analysis 2026

ORCX — Stock

The Defiance Daily Target 2X Long ORCL ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Oracle Corporation (NYSE: ORCL). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds and there is no guarantee that the Fund will meet its stated objective. The Fund should not be expected to provide 2 times the cumulative return of ORCL for periods greater than a single trading day.

Full ORCX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ORCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORCX vs SCHD ORCX vs JEPI ORCX vs O ORCX vs KO ORCX vs MAIN ORCX vs ABBV ORCX vs MRK ORCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.